In this study, we proved that Runx2 as an oncogene enhanced proliferation and migration of ccRCC cells by inhibiting the transcription level of tumor suppressor NOLC1, revealing a novel oncogenic mechanism of Runx2 in cancer progression. This evidence concerns the gene RUNX2 and nonpapillary renal cell carcinoma.